Reply To Clarification On Price Movement Sought By BSE Limited
Filed with BSE · · 1 page · English
Summary by 6ix AI
This filing is a response to a clarification request from BSE Limited regarding price movement of the company's shares. Starsource Multitrade Limited confirms that it has disclosed all relevant information affecting its operations and performance as required by regulations. The company emphasizes that the share price movement is driven by market factors and reiterates its commitment to regulatory compliance.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
For, STARSOURCE MULTITRADE LIMITED (Formerly known as Chemo Pharma Laboratories Limited) ________________________________________________________________________________________________________ Registered Office: 5 - Kumud Apartment CHS Ltd, Karnik Road, Chikan Ghar, Kalyan,– 421301, India Corporate Headquarter: 1016, North Plaza, Near D Mart, Motera, Ahmedabad– 380005, India Ph: +91-22-22078381 /
Starsource Multitrade Limited on 6ix
Earlier from Starsource Multitrade
- Starsource Multitrade Limited Press Release Mar 30 2026
- Closure of Trading Window
- Starsource Multitrade Limited Press Release Feb 16 2026
- Revised Outcome Of Board Meeting Held On February 12, 2026
- Starsource Multitrade Limited Press Release Feb 13 2026
Later from Starsource Multitrade
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Starsource Multitrade Limited Press Release Apr 06 2026
- Board Meeting Intimation for Considering Audited Financial Results For The Fourth Quarter And Financial Year Ended March 31, 2026 Along With The Auditors Report Thereon.
- Starsource Multitrade Limited Press Release May 25 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication
Follow Starsource Multitrade into a list and get an email when it puts out news.
Follow Starsource Multitrade